Table 1.

Changes in the patient’s rTMS application, CRS-R score, upper ARAS status, and medications

Duration from onset (months)	5 months	→ rTMS	7 months	→ No rTMS	9 months	→ rTMS	10 months
CRS-R	4		13		13		13 (higher cognition: improved)
Change of upper ARAS		Rt prefrontal lobe ↑		Rt prefrontal lobe ↓		Rt prefrontal lobe ↑
Drugs		levodopa 750 mg, amantadine 200 mg, bromocriptine 10 mg, zolpidem 10 mg, baclofen 75 mg		levodopa 500 mg, amantadine 150 mg, bromocriptine 3.75 mg		levodopa 500 mg, amantadine 150 mg, bromocriptine 3.75 mg

rTMS repetitive transcranial magnetic stimulation; CRS-R Coma Recovery Scale-Revised; ARAS ascending reticular activating system